A photoactivated Ir(<scp>iii</scp>) complex targets cancer stem cells and induces secretion of damage-associated molecular patterns in melanoma cells characteristic of immunogenic cell death

Abstract

The new iridium complex selectively targets cancer stem cells and has potential to induce immunogenic cell death in cancer cells.